Related Experiment Video
Updated: Sep 6, 2025
06:55
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.6K
Award rate inequities in biomedical research
Alessandra Zimmermann1, Richard Klavans2, Heather M Offhaus3
1Proposal Analytics, Inc., Wayne, PA, United States of America.
Plos One
|July 1, 2022
Summary
Racial and ethnic disparities exist in biomedical research funding. Black/African American and Asian researchers face disadvantages in proposal awards compared to White researchers, indicating a need for intervention.
Area of Science:
- Biomedical research
- Health equity
- Science funding
Background:
- Analyzing institutional research proposal databases offers insights into science funding parity.
- Understanding funding disparities is crucial for promoting equity in scientific research.
Purpose of the Study:
- To analyze the relationship between race/ethnicity and extramural research proposal and award rates.
- To determine if researchers alter submission strategies due to funding inequities.
Main Methods:
- Analysis of 14,263 biomedical research proposals (2010-2022) at the University of Michigan Medical School.
- Measurement of proposal submission and award rates across racial/ethnic groups and funding categories (R01, federal, industry, non-profit).
Main Results:
- Racial/ethnic groups employed distinct proposal submission strategies.
- Black/African American researchers experienced lower award rates across all categories.
- Black/African American researchers submitted fewer R01 and federal grants, and more non-profit grants.
Conclusions:
- Significant differences in proposal submission strategies and award rates exist among racial/ethnic groups.
- Black/African American and Asian researchers are disadvantaged in funding compared to White researchers.
- The study's methodology is replicable, offering opportunities for interventions to improve equity.
More Related Videos
Related Concept Videos
01:22Bias
4.8K
Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
4.8K
01:29Bias in Epidemiological Studies
611
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
611
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
169
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
169
01:16Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K
01:56Ethics in Research
23.8K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.8K
01:52Regression Toward the Mean
6.5K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.5K